Brii Biosciences Limited
HKEX:2137.HK
1.09 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 489.65 | 1,190.572 | 2,855.093 | 1,034.965 | 880.359 |
| Short Term Investments
| 2,171.011 | 1,806.812 | 499.647 | 20 | 0 |
| Cash and Short Term Investments
| 2,660.661 | 2,997.384 | 3,354.74 | 1,054.965 | 880.359 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 122.117 | 79.515 | 59.201 | 37.877 | 5.098 |
| Total Current Assets
| 2,782.778 | 3,076.899 | 3,413.941 | 1,092.842 | 885.457 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 5.609 | 19.522 | 33.435 | 43.919 | 56.77 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 267.42 | 146.887 | 9.506 | 12.222 | 0 |
| Goodwill and Intangible Assets
| 267.42 | 146.887 | 9.506 | 12.222 | 0 |
| Long Term Investments
| 142.444 | -1,660.784 | -347.616 | 96.547 | 94.88 |
| Tax Assets
| -142.444 | 1,660.784 | 0 | 0 | 0 |
| Other Non-Current Assets
| 142.444 | 148.541 | 502.433 | 22.414 | 2.317 |
| Total Non-Current Assets
| 415.473 | 314.95 | 197.758 | 175.102 | 153.967 |
| Total Assets
| 3,198.251 | 3,391.849 | 3,611.699 | 1,267.944 | 1,039.424 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 0 | 0 | 0 | 0 | 0 |
| Short Term Debt
| 3.156 | 9.5 | 8.969 | 8.021 | 8.07 |
| Tax Payables
| 2.011 | 1.861 | 1.653 | 1.019 | 0.53 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 122.713 | 219.613 | 271.744 | 567.214 | 53.814 |
| Total Current Liabilities
| 125.869 | 229.113 | 280.713 | 575.235 | 61.884 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 0 | 3.156 | 12.647 | 20.306 | 27.043 |
| Deferred Revenue Non-Current
| 0 | 2.083 | 7.083 | 12.083 | 27.915 |
| Deferred Tax Liabilities Non-Current
| 0 | -2.083 | -7.083 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 2.083 | 7.083 | 2,403.022 | 1,535.343 |
| Total Non-Current Liabilities
| 0 | 5.239 | 19.73 | 2,435.411 | 1,590.301 |
| Total Liabilities
| 125.869 | 234.352 | 300.443 | 3,010.646 | 1,652.185 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.024 | 0.024 | 0.023 | 0.007 | 0.007 |
| Retained Earnings
| -6,697.039 | -6,522.21 | -6,037.898 | -1,874.049 | -684.449 |
| Accumulated Other Comprehensive Income/Loss
| 3,119.016 | 364.687 | 63.713 | 61.421 | 9.407 |
| Other Total Stockholders Equity
| 6,697.039 | 9,352.113 | 9,317.066 | 74.332 | 62.274 |
| Total Shareholders Equity
| 3,119.04 | 3,194.614 | 3,342.904 | -1,738.289 | -612.761 |
| Total Equity
| 3,072.382 | 3,157.497 | 3,311.256 | -1,742.702 | -612.761 |
| Total Liabilities & Shareholders Equity
| 3,198.251 | 3,391.849 | 3,611.699 | 1,267.944 | 1,039.424 |